Acetazolamide Challenge With Perfusion in the Prediction of Cerebral Vasospasm
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The investigators propose a technique using cone beam CT perfusion (CBCTP) imaging with an
acetazolamide challenge as a potential diagnostic tool to detect a defect in cerebral
autoregulation at a time when it has not yet caused clinically apparent signs or symptoms. 30
participants will be enrolled at the University of Wisconsin - Madison and can expect to be
on study for about 2 weeks.